ArticleCancers2020

Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance.

Magdalena Rausch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.